NOSTRAND ROBERT L VAN Insider Trading $OSIP OSI PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for NOSTRAND ROBERT L VAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NOSTRAND ROBERT L VAN. NOSTRAND ROBERT L VAN is VP, & Chief Financial Officer in OSI PHARMACEUTICALS INC ($OSIP) and Director in METABOLIX, INC. ($MBLX) and in ACHILLION PHARMACEUTICALS INC ($ACHN) and Director in ACHILLION PHARMACEUTICALS INC ($ACHN) and Director in SELLAS Life Sciences Group, Inc. ($GALE) and Director in Enumeral Biomedical Holdings, Inc. ($ENUM) and Director in Intra-Cellular Therapies, Inc. ($ITCI).
NOSTRAND ROBERT L VAN in OSI PHARMACEUTICALS INC
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of NOSTRAND ROBERT L VAN: VP, & Chief Financial Officer
Holdings: 4,899 shares
Latest Transaction: May 03 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of NOSTRAND ROBERT L VAN in OSI PHARMACEUTICALS INC
Sentiment: All, ACHN, ENUM, ITCI, OSIP, SLS, MBLX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.14 | 21 | 1,221 | 6,567 | 6.6 K to 6.6 K (-0.32 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.12 | 12 | 697 | 6,588 | 6.6 K to 6.6 K (-0.18 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 58.10 | 131 | 7,611 | 6,600 | 6.7 K to 6.6 K (-1.95 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 57.82 | 24 | 1,388 | 6,731 | 6.8 K to 6.7 K (-0.36 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 57.81 | 143 | 8,267 | 6,755 | 6.9 K to 6.8 K (-2.07 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 57.80 | 12 | 694 | 6,898 | 6.9 K to 6.9 K (-0.17 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 57.76 | 24 | 1,386 | 6,910 | 6.9 K to 6.9 K (-0.35 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 57.75 | 582 | 33,611 | 6,934 | 7.5 K to 6.9 K (-7.74 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 7.09 | 345 | 2,447 | 7,516 | 7.2 K to 7.5 K (+4.81 %) |
| Aug 04 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 2,405 | 21,645 | 7,171 | 4.8 K to 7.2 K (+50.46 %) |
| Jul 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 2,750 | 24,750 | 2,405 | |
| Jul 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 70.00 | 18 | 1,260 | 4,766 | 4.8 K to 4.8 K (-0.38 %) |
| Jul 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 69.97 | 48 | 3,359 | 4,784 | 4.8 K to 4.8 K (-0.99 %) |
| Jul 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 69.96 | 240 | 16,790 | 4,832 | 5.1 K to 4.8 K (-4.73 %) |
| Jul 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 69.95 | 1,997 | 139,690 | 5,072 | 7.1 K to 5.1 K (-28.25 %) |
| Jul 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 69.52 | 447 | 31,075 | 7,069 | 7.5 K to 7.1 K (-5.95 %) |
| Jul 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 2,750 | 24,750 | 7,516 | 4.8 K to 7.5 K (+57.70 %) |
| Jun 21 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | A | 67.63 | 17,100 | 1,156,473 | 17,100 | |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 2,750 | 24,750 | 5,155 | |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.81 | 22 | 1,800 | 4,766 | 4.8 K to 4.8 K (-0.46 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.80 | 33 | 2,699 | 4,788 | 4.8 K to 4.8 K (-0.68 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.70 | 167 | 13,644 | 4,821 | 5 K to 4.8 K (-3.35 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.55 | 135 | 11,010 | 4,988 | 5.1 K to 5 K (-2.64 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.52 | 33 | 2,690 | 5,123 | 5.2 K to 5.1 K (-0.64 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.50 | 623 | 50,775 | 5,156 | 5.8 K to 5.2 K (-10.78 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.34 | 178 | 14,478 | 5,779 | 6 K to 5.8 K (-2.99 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.30 | 293 | 23,821 | 5,957 | 6.3 K to 6 K (-4.69 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.20 | 31 | 2,517 | 6,250 | 6.3 K to 6.3 K (-0.49 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.06 | 289 | 23,425 | 6,281 | 6.6 K to 6.3 K (-4.40 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.00 | 946 | 76,626 | 6,570 | 7.5 K to 6.6 K (-12.59 %) |
| Jun 03 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 2,750 | 24,750 | 7,516 | 4.8 K to 7.5 K (+57.70 %) |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 2,750 | 24,750 | 7,905 | |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 73.51 | 562 | 41,313 | 4,766 | 5.3 K to 4.8 K (-10.55 %) |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 73.50 | 1,492 | 109,662 | 5,328 | 6.8 K to 5.3 K (-21.88 %) |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 73.42 | 321 | 23,569 | 6,820 | 7.1 K to 6.8 K (-4.50 %) |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 72.93 | 95 | 6,928 | 7,141 | 7.2 K to 7.1 K (-1.31 %) |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 72.62 | 49 | 3,559 | 7,236 | 7.3 K to 7.2 K (-0.67 %) |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 72.55 | 48 | 3,482 | 7,285 | 7.3 K to 7.3 K (-0.65 %) |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 72.51 | 112 | 8,122 | 7,333 | 7.4 K to 7.3 K (-1.50 %) |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 72.50 | 71 | 5,148 | 7,445 | 7.5 K to 7.4 K (-0.94 %) |
| May 05 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 2,750 | 24,750 | 7,516 | 4.8 K to 7.5 K (+57.70 %) |
| Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 1,250 | 11,250 | 10,655 | |
| Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 82.30 | 255 | 20,988 | 4,766 | 5 K to 4.8 K (-5.08 %) |
| Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 81.61 | 162 | 13,220 | 5,021 | 5.2 K to 5 K (-3.13 %) |
| Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 80.90 | 156 | 12,620 | 5,183 | 5.3 K to 5.2 K (-2.92 %) |
| Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 80.70 | 630 | 50,841 | 5,339 | 6 K to 5.3 K (-10.55 %) |
| Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 80.50 | 47 | 3,784 | 5,969 | 6 K to 6 K (-0.78 %) |
| Apr 27 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 1,250 | 11,250 | 6,016 | 4.8 K to 6 K (+26.23 %) |
| Apr 21 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 833 | 7,497 | 11,905 | |
| Apr 21 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 40.00 | 833 | 33,320 | 4,766 | 5.6 K to 4.8 K (-14.88 %) |
| Apr 21 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 833 | 7,497 | 5,599 | 4.8 K to 5.6 K (+17.48 %) |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Option Exercise | M | 9.00 | 667 | 6,003 | 12,738 | |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.34 | 29 | 1,112 | 4,766 | 4.8 K to 4.8 K (-0.60 %) |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.33 | 32 | 1,227 | 4,795 | 4.8 K to 4.8 K (-0.66 %) |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.30 | 218 | 8,349 | 4,827 | 5 K to 4.8 K (-4.32 %) |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.25 | 52 | 1,989 | 5,045 | 5.1 K to 5 K (-1.02 %) |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.24 | 285 | 10,898 | 5,097 | 5.4 K to 5.1 K (-5.30 %) |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.23 | 14 | 535 | 5,382 | 5.4 K to 5.4 K (-0.26 %) |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.20 | 35 | 1,337 | 5,396 | 5.4 K to 5.4 K (-0.64 %) |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Sell | S | 38.18 | 2 | 76 | 5,431 | 5.4 K to 5.4 K (-0.04 %) |
| Apr 02 2004 | OSIP | OSI PHARMACEUTICAL ... | VAN NOSTRAND ROBERT L | VP, & Chief Financi ... | Buy | M | 9.00 | 667 | 6,003 | 5,433 | 4.8 K to 5.4 K (+13.99 %) |